Derbyshire Medicines Management and Clinical Policies
GREEN after consultant/specialist initiation: for all licensed uses (e.g. Breast cancer). (Decision date - August 2016)
GREEN after consultant/specialist initiation: Unlicensed use for bicalutamide induced gynaecomastia in men. To be continued for the duration of bicalutamide in the treatment of prostate cancer. (Decision date - July 2016)
